Theravance Biopharma, Inc. (TBPH)
17.08
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
17.08
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Cash and Short Term Investments (Annual) : 315.36M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 315.36M |
| December 31, 2024 | 88.35M |
| December 31, 2023 | 102.43M |
| December 31, 2022 | 327.48M |
| December 31, 2021 | 173.46M |
| December 31, 2020 | 292.94M |
| December 31, 2019 | 280.83M |
| December 31, 2018 | 505.28M |
| Date | Value |
|---|---|
| December 31, 2017 | 348.57M |
| December 31, 2016 | 501.10M |
| December 31, 2015 | 172.43M |
| December 31, 2014 | 254.61M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Zymeworks, Inc. | 228.80M |
| Viatris, Inc. | 1.454B |
| Ocular Therapeutix, Inc. | 737.06M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Corcept Therapeutics, Inc. | 372.15M |